LTF and inflammatory bowel disease: There have been reports indicating that lactoferrin can inhibit SARS-CoV-2 infection in the nanomolar range in cell models [27] and lactoferrin can be a carrier for drug delivery in the treatment of inflammatory bowel disease [28].